Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Rational design of vaccines

Nature Medicine volume 3, pages 374–376 (1997)Cite this article

The recombinant pertussis vaccine induces early and long-lasting protection

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nossal, G.J.V. Immunogenicity, 309–319 (Liss, New York, 1990).

  2. Edwards, K.M. et al. Comparison of 13 acellular pertussis vaccines: Overview and serologic response. Pediatrics 96, 548–557 (1995).

    CAS  PubMed  Google Scholar 

  3. Ramon, G. Sur la toxine et sur I'anatoxine diphtheriques. Ann. Inst. Pasteur 38, 1–10 (1924).

    CAS  Google Scholar 

  4. Pizza, M. et al. Mutants of pertussis toxin suitable for vaccine development. Science 246, 497–500 (1989).

    Article  CAS  Google Scholar 

  5. Hewlett, E.L. Acellular pertussis trial. Pediatrics 98, 800 (1996).

    CAS  PubMed  Google Scholar 

  6. Greco, D. et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334, 341–348 (1996).

    Article  CAS  Google Scholar 

  7. Greco, D. et al. A difference in relative efficacy of two DTaP vaccines in continued blinded observation of children following a clinical trial. Pediatric Res. 39, 173A (1996).

    Article  Google Scholar 

  8. Pizza, M. et al. A genetically detoxified derivative of heat labile E. coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 180, 2147–2153 (1994).

    Article  CAS  Google Scholar 

  9. Douce, G. et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyl-transferase activity act as non-toxic mucosal adjuvants. Proc. Natl. Acad. Sci. USA 92, 1644–1648 (1995).

    Article  CAS  Google Scholar 

  10. Ibsen, P.H. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 14, 359–368 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chiron Vaccines, Via Fiorentina 1, 53100, Siena, Italy

    Rino Rappuoli

Authors
  1. Rino Rappuoli
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rappuoli, R. Rational design of vaccines. Nat Med 3, 374–376 (1997). https://doi.org/10.1038/nm0497-374

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0497-374

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing